论文部分内容阅读
我们用思密达治疗婴幼儿秋季腹泻80例,疗效显著。 1.资料与方法:80例均根据1986年长沙会议标准确诊。年龄3个月~2岁,发病在10天以内,腹泻次数≥4次/d,大便性状为水样或蛋花样,72例于发病后48~72小时内入院(占90%),未经正规治疗。入院后随机分成治疗组48例和对照组32例,两组资料有可比性。 2.治疗方法:治疗组口服思密达,3~6个月患儿每次1/4包,~1岁每次1/3包,~2岁每次1/2包,均为每日3次,疗程3~6天。对照组除14例静液病毒唑外,余者均按常规治疗。两组均根据脱水程度口服ORS液或静脉补液。 3.结果:治疗组显效(治疗后24~48小时腹泻≤2次/d,水分明显减少,大便外观成形或软便,
We use Smecta treatment of infantile autumn diarrhea in 80 cases, a significant effect. 1. Materials and Methods: 80 cases were diagnosed according to the 1986 Changsha meeting standard. Age 3 months to 2 years, incidence of less than 10 days, diarrhea ≥ 4 times / d, stool traits as water or egg-like pattern, 72 cases admitted within 48 to 72 hours after onset (90%), without Formal treatment. After admission, the patients were randomly divided into treatment group (n = 48) and control group (n = 32). The two groups of data were comparable. 2. Treatment: The treatment group oral Smecta, 3 to 6 months of children each 1/4 package, ~ 1 year old each 1/3 package, ~ 2 years old each time 1/2 package, are daily 3 times, 3 to 6 days course of treatment. In addition to 14 cases of hydronephrine in the control group, the remaining patients were treated as usual. Oral ORS fluid or intravenous rehydration was administered to both groups according to the degree of dehydration. 3. Results: The treatment group markedly effective (24-48 hours after treatment of diarrhea ≤ 2 times / d, significantly reduced water, stool appearance or soft stools,